Rejected at 5:25 p.m. May, 03, 2024 ] by herstein.jacob
Author: DillingerMed
Related Note: 1477011621149
Rationale for change

UW QID 1343
This is the best card I can find for this currently untagged UW QID. Basically, the question has a "novel" drug that is an unspecified adrenergic receptor(s) agonist with no antagonist properties. It shows that the drug causes immediate BP increase with slightly delayed bradycardia. This is from the vagal reflex bradycardia from the increased BP. This mimics phenylephrine's MOA and so I thought it might be an adequate card to tag.

Also added the Extra to beef it up a bit for the UW QID. I'm ambivalent about the Extra and would be ok with removing it to avoid bloat.

Rejection reason

will push as part of bulk suggestion with tags to some other cards that help identify the mystery drug

Extra Extra
Text
Phenylephrine causes reflex {{c1::bradycardia::HR}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy




Watch Sympathomimetics
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Phenylephrine



Watch Phenylephrine and Pseudoephedrine
Physeo

Bootcamp
Watch associated Bootcamp video - Vasodilation and Vasoconstriction : Pharmacologic Targets

Watch associated Bootcamp video - Autonomic System : Direct Sympathomimetics
OME

Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#UWorld::1343
#AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::01_Sympathomimetics #AK_Step1_v12::#Bootcamp::Cardiology::07_Vasodilation_and_Vasoconstriction::04_Pharmacologic_Targets #AK_Step1_v12::#UWorld::COMLEX::26711 #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::04_Sympathomimetics_&_Sympatholytics::08_Phenylephrine_and_Pseudoephedrine #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::11_Direct_Sympathomimetics #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::04_Bradycardia::Extra #AK_Step1_v12::#Pixorize::03_Pharmacology::23_Sympathomimetics_&_Sympatholytics_(New)::07_Phenylephrine #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::04_Pseudoephedrine,_Phenylephrine #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::03_Pseudoephedrine_phenylephrine #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#UWorld::Step::18618 #AK_Step1_v12::#UWorld::Step::1343 #AK_Step1_v12::#B&B::15_Neuro::04_Autonomic_Nervous_System::02_ANS_Drugs:_Norepinephrine::Extra #AK_Step1_v12::#UWorld::COMLEX::24454 #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::11_Sympathomimetics::*Direct::Phenylephrine #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::13_Sympatholytics_(alpha2-agonists)::*Sympatholytics_(a2-Agonists)::Phenylephrine #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#UWorld::COMLEX::25261 !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#OME_banner #AK_Step1_v12::#UWorld::Step::6811